2024 Clinic Management Labelling 
Hospital Pharmacy Europe
NOVEMBER 30, 2023
The final guidance is expected to be published in early January 2024. NICE’s recommendation is based on sebelipase alfa’s clinical effectiveness evidence from two single-arm, open-label, multicentre trials: LAL-CL08 and LAL-CL03.
IDStewardship
JULY 27, 2022
Pharmacists also undertake enhanced roles through nationally commissioned services, including managing minor ailments to avoid the need for medical intervention and clinical management of uncomplicated UTIs using patient group directions. The target for the overall usage of antimicrobials is a reduction of 15% by 2024.
Expert insights. Personalized for you.
52 
Let's personalize your content